Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.

Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D, Vokes EE
J Clin Oncol. 2000 18 (2): 371-5

PMID: 10637252 · DOI:10.1200/JCO.2000.18.2.371

MeSH Terms (20)

Adult Aged Antineoplastic Agents Asthenia Bone Neoplasms Carcinoma, Renal Cell Diarrhea Drug Administration Schedule Female Flavonoids Humans Kidney Neoplasms Liver Neoplasms Lung Neoplasms Lymphatic Metastasis Male Middle Aged Piperidines Thrombosis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links